Ingredients Vyvanse contains lisdexamfetamine, which is an inactive prodrug
This activation then triggers the transcription of the nucleotide-binding oligomerization domain, leucine-rich repeat, and pyrin domain-containing protein 3 (NLRP3) gene, causing podocyte pyroptosis and contributing to the development of DKD[36]
Taking it in the morning is a great way to "prime" your bodys antioxidant defenses for the day ahead
[DOI] [PMC free article] [PubMed] [Google Scholar] Spiekerkoetter U., Huener G., Baykal T., Demirkol M., Duran M., Wanders R., Nezu J., Mayatepek E
Clinical studies (in both obesity and type 2 diabetes) consistently show that GLP-1 RA treatment leads to less hunger, increased satiety, and spontaneous decreases in daily caloric consumption (Zheng et al., 2024)